Seth Loring Harrison, Director at Akero Therapeutics, Inc. (AKRO), sold 86,537 shares at $40.28 ($3.5M) on 2022-10-28, disclosed to the SEC on 2022-11-01.
Open-market sale of $3.5M AKRO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.28 | 20,338 | $819K | 23.5% |
| 2 | $40.28 | 20,338 | $819K | 23.5% |
| 3 | $40.28 | 22,096 | $890K | 25.5% |
| 4 | $40.28 | 22,096 | $890K | 25.5% |
| 5 | $41.12 | 800 | $33K | 0.9% |
| 6 | $41.12 | 869 |
| $36K |
| 1.0% |
| Total | $40.30 avg | 86,537 | $3.5M | 100% |
| Filing → |
| STOK | BUY | 2020-11-25 | $14.6M | — | Filing → |
| AKRO | BUY | 2020-07-14 | $14.9M | — | Filing → |
| AKRO | BUY | 2019-06-25 | $14.4M | — | Filing → |